Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
1.210
-0.250 (-17.12%)
At close: Sep 17, 2025, 4:00 PM EDT
1.200
-0.010 (-0.83%)
After-hours: Sep 17, 2025, 7:17 PM EDT

Revenue by Product

Fiscal year is September - August.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Aug '24 Aug '23 Aug '22 Aug '21 Aug '20 2017 - 2019
Intellectual Property Licensing
457.99K
Log In
Log In
Log In
Log In
Upgrade
Intellectual Property Licensing Growth
211.98%
Log In
Log In
Log In
Log In
Upgrade
Business-to-business Product
5.39K
Log In
Log In
Log In
Log In
Upgrade
Business-to-business Product Growth
-87.80%
Log In
Log In
Log In
Log In
Upgrade
Research & Development
900.00
Log In
Log In
Log In
Log In
Upgrade
Research & Development Growth
-97.45%
Log In
Log In
Log In
Log In
Upgrade
Corporate
-
Log In
Log In
Log In
Log In
Upgrade
Corporate Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is September - August.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Aug '24 Aug '23 Aug '22 Aug '21 Aug '20 2017 - 2019
United States and Canada
464.28K
Log In
Log In
Log In
Log In
Upgrade
United States and Canada Growth
105.24%
Log In
Log In
Log In
Log In
Upgrade